These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15534187)

  • 21. Anesthesia in a child with homozygous porphobilinogen deaminase deficiency: a severe form of acute intermittent porphyria.
    Sheppard L; Dorman T
    Paediatr Anaesth; 2005 May; 15(5):426-8. PubMed ID: 15828996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.
    Nissen H; Petersen NE; Mustajoki S; Hansen TS; Mustajoki P; Kauppinen R; Hørder M
    Hum Mutat; 1997; 9(2):122-30. PubMed ID: 9067752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
    Mustajoki P
    Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries.
    Prabahar MR; Manorajan R; Sathiyakumar D; Soundararajan P; Jayakumar M
    Hemodial Int; 2008 Jan; 12(1):34-8. PubMed ID: 18271838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurological manifestations of acute intermittent porphyria.
    Pischik E; Kauppinen R
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):72-83. PubMed ID: 19268005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute intermittent porphyria: vector optimization for gene therapy.
    Yasuda M; Domaradzki ME; Armentano D; Cheng SH; Bishop DF; Desnick RJ
    J Gene Med; 2007 Sep; 9(9):806-11. PubMed ID: 17654633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
    Nunn AV; Gardner LC; Cox TM
    Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of acute intermittent porphyria carriers by molecular biologic methods.
    Bor M; Balogh K; Pusztai A; Tasnádi G; Hunyady L
    Acta Physiol Hung; 1999; 86(2):147-53. PubMed ID: 10741873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.
    Chen CH; Astrin KH; Lee G; Anderson KE; Desnick RJ
    J Clin Invest; 1994 Nov; 94(5):1927-37. PubMed ID: 7962538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria.
    Berger S; Stattmann M; Cicvaric A; Monje FJ; Coiro P; Hotka M; Ricken G; Hainfellner J; Greber-Platzer S; Yasuda M; Desnick RJ; Pollak DD
    Acta Neuropathol Commun; 2020 Mar; 8(1):38. PubMed ID: 32197664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism.
    Luder AS; Mamet R; Farbstein I; Schoenfeld N
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):19-22. PubMed ID: 19267997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute intermittent porphyria: characterization of two novel mutations in the porphobilinogen deaminase gene, one amino acid deletion (453-455delAGC) and one splicing aceptor site mutation (IVS8-1G>T).
    De Siervi A; Mendez M; Parera VE; Varela L; Batlle AM; Rossetti MV
    Hum Mutat; 1999 Oct; 14(4):355. PubMed ID: 10502788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
    von Brasch L; Zang C; Haverkamp T; Schlechte H; Heckers H; Petrides PE
    Blood Cells Mol Dis; 2004; 32(2):309-14. PubMed ID: 15003823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial occurrence of myoclonic epilepsy syndrome and acute intermittent porphyria.
    Varsik P; Buranová D; Kollár B; Traubner P; Bozek P; Mikulecký M
    Neuro Endocrinol Lett; 2005 Feb; 26(1):7-12. PubMed ID: 15726012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria.
    Delfau MH; Picat C; de Rooij FW; Hamer K; Bogard M; Wilson JH; Deybach JC; Nordmann Y; Grandchamp B
    J Clin Invest; 1990 Nov; 86(5):1511-6. PubMed ID: 2243128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of two missense variants in the hydroxymethylbilane synthase gene in the Israeli population, which differ in their associations with acute intermittent porphyria.
    Schneider-Yin X; Ulbrichova D; Mamet R; Martasek P; Marohnic CC; Goren A; Minder EI; Schoenfeld N
    Mol Genet Metab; 2008 Jul; 94(3):343-6. PubMed ID: 18406650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Porphyrins and porphyrias].
    Bogard C; Deybach JC
    Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():11-22. PubMed ID: 9827210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.